Extended spectrum beta lactamases (ESBL)

Extended spectrum beta lactamases (ESBLs) are enzymes that mediate resistance to extended-spectrum or third generation cephalosporins like ceftazidime, cefotaxime, and ceftriaxone and monobactams like aztreonam. ESBLs do not affect cephamycins like cefoxitin and cefotetan or carbapenems like meropenem or imipenem.

Add a Comment

Your email address will not be published. Comments will be displayed only after moderation.

Read previous post:
Myelodysplastic syndrome (MDS)

It is a heterogenous group of conditions with cytopenias, hypercellular / dysplastic marrow and is a premalignant condition. Dyserythropoesis manifest...

Close